Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...

Otherwise known as an artificial pancreas or closed-loop system, an automated insulin delivery (AID) system is a technology ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

Other people could be having problems with the same insulin pump, dental implant or glucose monitor that you use -- ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

Scientists recently unveiled a first-of-its-kind authentication protocol for wireless, battery-free, ultraminiaturized implants that ensures these devices remain protected while still allowing ...

Individuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...

The Artisan International Small-Mid Fund portfolio outperformed the MSCI ACWI ex USA SMID Index in Q4 of 2024. Click here to ...

SFC Fluidics, Inc. ("SFC") and Duracell U.S. Operations, Inc. ("Duracell") are collaborating to efficiently deliver power to SFC's dual-hormone insulin and glucagon delivery pod. The goal of this ...